Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection.

Around ( Figure 3 F) and caudally ( Figure 3 G) to the epicenter it is possible to observe a clear trend for the decrease of iNOS-positive cells in the IL-4-treated group, however, no statistically significant differences were found.

also in 19,460 other papers